(Press-News.org) A protein secreted with insulin travels through the bloodstream and accumulates in the brains of individuals with type 2 diabetes and dementia, in the same manner as the amyloid beta Αβ plaques that are associated with Alzheimer's disease, a study by researchers with the UC Davis Alzheimer's Disease Center has found.
The study is the first to identify deposits of the protein, called amylin, in the brains of people with Alzheimer's disease, as well as combined deposits of amylin and plaques, suggesting that amylin is a second amyloid as well as a new biomarker for age-related dementia and Alzheimer's.
"We've known for a long time that diabetes hurts the brain, and there has been a lot of speculation about why that occurs, but there has been no conclusive evidence until now," said UC Davis Alzheimer's Disease Center Director Charles DeCarli.
"This research is the first to provide clear evidence that amylin gets into the brain itself and that it forms plaques that are just like the amyloid beta that has been thought to be the cause of Alzheimer's disease," DeCarli said. "In fact, the amylin looks like the amyloid beta protein, and they both interact. That's why we're calling it the second amyloid of Alzheimer's disease."
"Amylin deposition in the brain: A second amyloid in Alzheimer's disease?" is published online in the Annals of Neurology.
Type 2 diabetes is a chronic metabolic disorder that increases the risk for cerebrovascular disease and dementia, a risk that develops years before the onset of clinically apparent diabetes. Its incidence is far greater among people who are obese and insulin resistant.
Amylin, or islet amyloid polypeptide, is a hormone produced by the pancreas that circulates in the bloodstream with insulin and plays a critical role in glycemic regulation by slowing gastric emptying, promoting satiety and preventing post-prandial spikes in blood glucose levels. Its deposition in the pancreas is a hallmark of type 2 diabetes.
When over-secreted, some proteins have a higher propensity to stick to one another, forming small aggregates, called oligomers, fibrils and amyloids. These types of proteins are called amyloidogenic and include amylin and Αβ. There are about 28 amyloidogenic proteins, each of which is associated with diseases.
The study was conducted by examining brain tissue from individuals who fell into three groups: those who had both diabetes and dementia from cerebrovascular or Alzheimer's disease; those with Alzheimer's disease without diabetes; and age-matched healthy individuals who served as controls.
The research found numerous amylin deposits in the gray matter of the diabetic patients with dementia, as well as in the walls of the blood vessels in their brains, suggesting amylin influx from blood circulation. Surprisingly, the researchers also found amylin in the brain tissue of individuals with Alzheimer's who had not been diagnosed with diabetes; they postulate that these individuals may have had undiagnosed insulin resistance. They did not find amylin deposits in the brains of the healthy control subjects.
"We found that the amylin deposits in the brains of people with dementia are both independent of and co-located with the Aβ, which is the suspected cause of Alzheimer's disease," said Florin Despa, assistant professor-in-residence in the UC Davis Department of Pharmacology. "It is both in the walls of the blood vessels of the brain and also in areas remote from the blood vessels.
"It is accumulating in the brain and we found signs that amylin is killing neurons similar to Αβ," he continued. "And that might be the answer to the question of 'What makes obese and type 2 diabetes patients more prone to developing dementia?'"
The researchers undertook the investigation after Despa and his colleagues found that amylin accumulates in the blood vessels and muscle of the heart. From this evidence, he hypothesized that the same thing might be happening in the brain. To test the hypothesis he received a pilot research grant through the Alzheimer's Disease Center.
The research was conducted using tissue from the brains of individuals over 65 donated to the UC Davis Alzheimer's Disease Center: 15 patients with Alzheimer's disease and type 2 diabetes; 14 Alzheimer's disease patients without diabetes; and 13 healthy controls. A series of tests, including Western blot, immunohistochemistry and ELISA (enzyme-linked immunosorbent assay) were used to test amylin accumulation in specimens from the temporal cortex.
In contrast with the healthy brains, the brain tissue infiltrated with amylin showed increased interstitial spaces, cavities within the tissue, sponginess, and blood vessels bent around amylin accumulation sites.
Despa said that the finding may offer a therapeutic target for drug development, either by increasing the rate of amylin elimination through the kidneys, or by decreasing its rate of oligomerization and deposition in diabetic patients.
"If we're smart about the treatment of pre-diabetes, a condition that promotes increased amylin secretion, we might be able to reduce the risk of complications, including Alzheimer's and dementia," Despa said.
INFORMATION:
Additional study authors are Kaleena Jackson, Gustavo A. Barisone, Elva Diaz and Lee-Way Jin, all of UC Davis.
The study was funded by National Science Foundation grant CBET 1133339 (F.D.); American Diabetes Association grant 1-13-IN-70 (F.D.); the University of California, Davis Alzheimer's Disease Pilot Project Program (F.D.); National Institute on Aging award P30AG010129 (C.D.); and a Vision Grant from the University of California, Davis Health System (F.D.).
The UC Davis Alzheimer's Disease Center is one of only 29 research centers designated by the National Institutes of Health's National Institute on Aging. The center's goal is to translate research advances into improved diagnosis and treatment for patients while focusing on the long-term goal of finding a way to prevent or cure Alzheimer's disease. Also funded by the state of California, the center allows researchers to study the effects of the disease on a uniquely diverse population. For more information, visit alzheimer.ucdavis.edu.
END
When faced with the choice of sacrificing time and energy for a loved one or taking the self-centered route, people's first impulse is to think of others, according to new research published in Psychological Science, a journal of the Association for Psychological Science.
"For decades psychologists have assumed that the first impulse is selfish and that it takes self-control to behave in a pro-social manner," says lead researcher Francesca Righetti of VU University Amsterdam in the Netherlands. "We did not believe that this was true in every context, and especially not ...
Today, on National HIV Testing Day, the Rollins School of Public Health at Emory University launched its annual update of AIDSVu, including new interactive online maps that show the latest HIV prevalence data for 20 U.S. cities by ZIP code or census tract. AIDSVu also includes new city snapshots displaying HIV prevalence alongside various social determinants of health – such as poverty, lack of health insurance and educational attainment.
AIDSVu -- the most detailed publicly available view of HIV prevalence in the United States -- is a compilation of interactive online ...
Understanding how the protein km23-1 enables in the spread of colon cancer may lead to new treatments for the disease, according to researchers at Penn State College of Medicine.
Previous research shows that km23-1 is involved in the movement of cancer cells and in the control of specific proteins at the leading edge of moving cells. Kathleen Mulder, professor of biochemistry and molecular biology, who discovered the protein, now says km23-1 is used in the cancer cell's ability to move out of a tumor in the early stages of invasion.
"km23-1 may be able to help in this ...
(SACRAMENTO, Calif.) — In what researchers say is the first public health study of the aerial mosquito spraying method to prevent West Nile virus, a UC Davis study analyzed emergency department records from Sacramento area hospitals during and immediately after aerial sprayings in the summer of 2005. Physicians and scientists from the university and from the California Department of Public Health found no increase in specific diagnoses that are considered most likely to be associated with pesticide exposure, including respiratory, gastrointestinal, skin, eye and neurological ...
A single dose of a commonly-prescribed attention deficit hyperactivity disorder (ADHD) drug helps improve brain function in cocaine addiction, according to an imaging study conducted by researchers from the Icahn School of Medicine at Mount Sinai. Methylphenidate (brand name Ritalin®) modified connectivity in certain brain circuits that underlie self-control and craving among cocaine-addicted individuals. The research is published in the current issue of JAMA Psychiatry, a JAMA network publication.
Previous research has shown that oral methylphenidate improved brain function ...
COLUMBUS, Ohio – Higher levels of omega-3 fatty acids in the blood may reduce the risk for hip fractures in postmenopausal women, recent research suggests.
Scientists analyzed red blood cell samples from women with and without a history of having a broken hip. The study showed that higher levels of omega-3 fatty acids from both plant and fish sources in those blood cells were associated with a lower likelihood of having fractured a hip.
In addition to omega-3s, the researchers looked at omega-6 fatty acids, which are generally plentiful in a Western diet. The study ...
KNOXVILLE—A mother's prolonged use of antibacterial soaps containing the chemical triclocarban may harm nursing babies, according to a recent study from the University of Tennessee, Knoxville.
The study, which was conducted on rats, showed that exposure to the compound may reduce the survival rates of babies.
Rebekah Kennedy, a UT graduate student pursuing a dual master's degree in public health and nutrition, and Jiangang Chen, an assistant professor in the UT Department of Public Health, presented the results this month at the Endocrine Society's 95th Annual Meeting ...
WASHINGTON D.C., June 26, 2013 -- A new report by an independent task force commissioned by the American Association of Physicists in Medicine (AAPM), has found that people absorb less radiation from airport X-ray backscatter scanner than they do while standing in line waiting for the scan itself.
Measurements made on two scanners in active use at Los Angeles International Airport (LAX), as well as seven other scanners not in active use at the time of measurement, found that full-body scanners deliver a radiation dose equivalent to what a standard man receives every 1.8 ...
This news release is available in Spanish.
Gemini Observatory's Planet-Finding Campaign finds that, around many types of stars, distant gas-giant planets are rare and prefer to cling close to their parent stars. The impact on theories of planetary formation could be significant.
Finding extrasolar planets has become so commonplace that it seems astronomers merely have to look up and another world is discovered. However, results from Gemini Observatory's recently completed Planet-Finding Campaign – the deepest, most extensive direct imaging survey to date – show ...
Chicago (June 27, 2013): Recurrence of melanoma skin cancer 10 or more years after initial treatment is more common than previously thought, occurring in more than one in 20 patients. However, according to a new study, these patients tend to live longer after their cancer returns than patients whose melanoma recurs in the first three years. The study results appear in the July issue of the Journal of the American College of Surgeons.
"For patients with melanoma, survival beyond 10 years without a recurrence has been considered nearly synonymous with a cure," said principal ...
